Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-09-02

Clinical Trial Update: Influence of an Omega-3 SPM Supplement on Quality of Life [EARLY_Phase 1]

View source ↗

Summary

An early-phase trial evaluating an omega-3 specialized pro-resolving mediator (SPM) supplement for quality of life in chronic pain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Omega-3 SPM supplement (Specialized pro-resolving mediator derived from omega-3 fatty acids)

Snippet

Sponsor: National University of Natural Medicine | Conditions: Chronic Pain | EARLY_Phase 1 | Status: COMPLETED